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In 1998, the American Academy of Neurology published its prior position on physician-
hastened death, titled “Assisted suicide, euthanasia, and the neurologist.” In that statement, the
American Academy of Neurology (AAN) expressed its vigorous opposition to its members’
participation in either physician-assisted suicide (PAS) (prescription without clinician ad-
ministration) or euthanasia (prescription with clinician administration).1 At that time, physi-
cian participation in either of these hastened-death practices was illegal in all US jurisdictions
except Oregon.
In 1994, Oregon became the first US jurisdiction to enact legislation legalizing PAS, although
litigation prevented the law from going into effect until October 1997.2 Since then, PAS, when
requested by terminally ill adults and practiced within regulated boundaries, has become legal in
6 states (California, Colorado, Oregon, Montana, Vermont, and Washington) and in the
District of Columbia.2 One in 5 US citizens and the neurologists who care for them now have
lawful access to PAS.3 This legal trend appears to parallel increasing public support for lawful
physician-hastened death (LPHD), which approximates 70% of 1,000 surveyed individuals in
one poll.4
AAN members are ethically guided by its Code of Professional Conduct (CPC). This docu-
ment, although not specifically addressing hastened-death practices, directs its members to
“relieve the suffering” and to “respect the wishes” of dying patients.5 As a consequence of
evolving law, the prior AAN position on PAS, and CPC guidance, AAN members practicing in
PAS-lawful jurisdictions may feel conflicted when their dying patients request assistance in
hastened death. In consideration of this, the Ethics, Law and Humanities Committee (a joint
committee of the AAN, the American Neurological Association, and the Child Neurology
Society), after 2 years of deliberation, unanimously recommended to the Boards of the AAN
and the AAN Institute that the 1998 position be retired. The Ethics, Law and Humanities
Committee undertook this difficult consideration while respectfully acknowledging that there
remain cogent opinions from those who both endorse and oppose LPHD practices. On
December 1, 2016, the AAN and the AAN Institute unanimously endorsed this recommen-
dation. The Child Neurology Society has subsequently endorsed this position whereas the
American Neurological Association has chosen to recuse itself from rendering a decision. The
following briefly summarizes the basis for the Ethics, Law and Humanities Committee rec-
ommendations to the AAN and AAN Institute Boards.
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The Ethics, Law and Humanities Committee was influenced
by the results of a 2014 AAN-sponsored Ethics, Law and
Humanities Committee survey that suggested that a notable
percentage of AAN members might feel bound by con-
science to comply with the wishes of their dying patients for
assistance in hastening death (appendix e-1, http://links.
lww.com/WNL/A270). In this survey, more than 70% of
responding members in PAS-lawful states endorsed LPHD
as an ethically permissible behavior, and more than 50% of
these same individuals reported that they would be willing to
assist their patients in lawful hastened death. The Ethics,
Law and Humanities Committee also recognized that the
AAN vision (to be indispensable to its members) was po-
tentially jeopardized by conflicting guidance provided by
changing PAS laws, the AAN CPC, and the existing 1998
Position Statement.
In their recommendation, the Ethics, Law and Humanities
Committee purposely chose to adopt the term LPHD (syn-
onymous with PAS in the United States). The committee
chose LPHD in lieu of PAS to remove any ambiguity re-
garding patient motivation, which is not to commit suicide per
se, but to hasten death in order to relieve suffering. The
committee avoided terms such as assisted death or dying,
which if misinterpreted in a literal sense could be erroneously
construed to include the beneficial assistance in the dying
process provided by palliative care.
The Ethics, Law and Humanities Committee approached
the ethical analysis of LPHD from 2 perspectives—the
boundaries of individual physicians’ fiduciary responsibility
to their patients and the effect of hastened death practice on
societal trust of the medical profession as a whole. In
consideration of the moral boundaries of an individual
physician’s care of a dying patient, the committee considers
LPHD to be morally distinctive from other medical inter-
ventions that do or may hasten death such as the with-
drawal of life-sustaining treatments, palliative sedation, and
euthanasia. Unlike these interventions, both the request for
and administration of the intervention in LPHD when
regulated remain under the control of the patient. The
Ethics, Law and Humanities Committee endorses the belief
that the primary role of a physician is to prevent and treat
disease whenever possible. At the same time, the committee
strongly endorses the provision of palliative care to alleviate
suffering in patients with illnesses that are unresponsive to
disease-specific treatments. In addition, it expresses sup-
port for improved availability of palliative care services,
palliative care education for AAN members, and palliative
care research intended to identify more effective means to
alleviate refractory suffering of dying patients. By doing so,
it hopes to minimize future patient interest in hastened
death. However, the committee recognizes that palliative
care interventions may not be universally effective for all
terminally ill patients who may seek hastened death assis-
tance from AAN members, particularly with spiritual or
existential suffering.6
The Ethics, Law and Humanities Committee also con-
sidered the potential effect of any change in the AAN
position on the public trust of the medical profession and
AAN members in particular. Relevant to this concern, it
reviewed the 18-year experience of LPHD in Oregon and
the opinions of those who have critiqued it.7,8 The com-
mittee recognizes that many but not all who have reviewed
and written on this experience have been reassured by the
safeguards provided. This reassurance arises in part from
the knowledge that only 2-thirds of individuals ingest the
prescription they receive.2 More importantly, reassurance
stems from the safeguards provided by regulations that
require a terminally ill adult resident of Oregon with ca-
pacity for decision-making and capability of self-
administration to request assistance from a physician
twice in an interval of 15 days supplemented by a written
request cosigned by 2 witnesses. In addition, the patient
must be apprised of alternatives to PAS and undergo
psychiatric assessment if in the judgment of either the
prescribing physician or the required consulting physician
the patient’s judgment is psychologically impaired. Failure
to follow these regulations is illegal and reportable. While
reassuring, the committee acknowledges that hastened
death practices should be continually monitored as they
remain potentially susceptible to erosion over time.8–10
In consideration of the Ethics, Law and Humanities Com-
mittee recommendations, the AAN Board of Directors
carefully deliberated this important issue, taking into ac-
count the evolving legal environment, all aspects of the
ethical debate, the reported values of AAN members, and
expectations of their adult patients dying of neurologic ill-
ness. Accordingly, the AAN has decided to retire its 1998
position on “Assisted suicide, euthanasia, and the neurolo-
gist” and to leave the decision of whether to practice or not
to practice LPHD to the conscientious judgment of its
members acting on behalf of their patients. The Ethics, Law
and Humanities Committee and the AAN make no attempt
to influence an individual member’s conscience in consid-
eration of participation or nonparticipation in LPHD.
Although the AAN endorses the belief that LPHD decision-
making is ideally made within a well-established patient/
Glossary
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doctor relationship, it places no obligation on its members to
identify another physician willing to participate should their
conscience preclude them from participation. The AAN
remains opposed to member participation in euthanasia,
which remains illegal in all US jurisdictions, regardless of its
legal status in the jurisdiction in which an AANmember may
practice.
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